Inferences for current chronic graft-versus-host-disease free and relapse free survival

BMC Med Res Methodol. 2022 Dec 13;22(1):318. doi: 10.1186/s12874-022-01771-x.

Abstract

This paper provides the methodologies of a new summary curve that measures the dynamic outcome following allogenic hematopoietic cell transplantation. This new summary curve computes the probabilities that a patient is alive in remission and free of severe-to-moderate chronic graft-versus-host disease (GVHD) over time. The probability is called Current chronic GVHD-free, Relapse-Free Survival (CGRFS). Based on a multistate model depicting the possible states that a patient may experience after transplant, CGRFS can be formulated as a linear combination of five survival functions. This method is known as the model-free approach. In this paper we provide the inferences of the model-free approach, including estimation of CGRFS, precision evaluation and comparison of CGRFS between two independent samples.

Keywords: GRFS; Kaplan-Meier estimator; Multistate; Product integral.

Publication types

  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Bronchiolitis Obliterans Syndrome*
  • Chronic Disease
  • Disease-Free Survival
  • Graft vs Host Disease*
  • Hematopoietic Stem Cell Transplantation* / adverse effects
  • Humans
  • Recurrence